Market Tracker

03/30 6:27am ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

3.95
Delayed Data
As of Mar 29
 +0.05 / +1.28%
Today’s Change
1.90
Today|||52-Week Range
5.29
+19.70%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.90
Today’s open3.85
Day’s range3.85 - 3.95
Volume9,095
Average volume (3 months)21,041
Market cap$59.6M
Dividend yield--
Data as of 03/29/2017

Growth & Valuation

Earnings growth (last year)+79.47%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+171.56%
P/E ratioNM
Price/Sales2.61
Price/Book8.39

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc+0.02+1.27%
OREXOrexigen Therapeutic...-0.25-5.90%
GLMDGalmed Pharmaceutica...-0.12-2.54%
NTECIntec Pharma Ltd0.000.00%
Data as of 03/29/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$11.9M
Annual profit (last year)-$13.2M
Net profit margin-110.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts